Abstract
Guus R. M. van den Heuvel, Bas L R Mandos, Hans J.M. Smit, Olga C.J. Schuurbiers, Erik H.J.G. Aarntzen, Iris Walraven, Francesco Ciompi, Michel M. van den Heuvel
Abstract
Authors
Institutions
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Sex disparities in advanced non-small cell lung cancer survival: a Danish nationwide study
10.1016/j.lungcan.2025.108485 · 2025
Sex differences in lung cancer treatment and outcomes at a large hybrid academic-community practice
10.1016/j.jtocrr.2022.100307 · 2022
Survival differences by gender for resected non-small cell lung cancer: a retrospective analysis of 12,509 cases in a Japanese lung cancer registry study
10.1097/jto.0b013e3181f1923b · 2010
Evaluating prognostic factors for sex differences in lung cancer survival: findings from a large Australian cohort
10.1016/j.jtho.2022.01.016 · 2022
Sex and survival after surgery for lung cancer: a Swedish nationwide cohort
10.1016/j.chest.2020.11.010 · 2021
Insights into sex differences in perioperative outcomes of non-small cell lung cancer patients
10.21037/tlcr-24-336 · 2024
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up
10.1093/annonc/mdx222 · 2017
Lung cancer, version 4.2024, NCCN clinical practice guidelines in oncology
10.6004/jnccn.2204.0023 · 2024
Trends and variations in treatment of stage I-III non-small cell lung cancer from 2008 to 2018: a nationwide population-based study from the Netherlands
Provenance
crossref
Confidence 100%
openalex
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
10.1016/j.lungcan.2021.03.013 · 2021
Is sex associated with the outcome of patients treated with radiation for nonsmall cell lung cancer
10.1002/cncr.24361 · 2009
Gender difference in treatment outcomes in patients with stage III non-small cell lung cancer receiving concurrent chemoradiotherapy
10.1093/jjco/hyp095 · 2009
Sex-based dimorphism of anticancer immune response and molecular mechanisms of immune evasion
10.1158/1078-0432.ccr-21-0136 · 2021
Radiotherapy induced immunogenic cell death by remodeling tumor immune microenvironment
10.3389/fimmu.2022.1074477 · 2022
Tumor-intrinsic determinants of immunogenic cell death modalities
10.1080/2162402x.2021.1893466 · 2021
Sex differences in the response to lung cancer and its relation to programmed cell death protein-1/programmed death-ligand-1 checkpoint therapies
10.3390/cancers17243953 · 2025
Estrogens, cancer and immunity
10.3390/cancers14092265 · 2022
Gender-specific differences in care-seeking behaviour among lung cancer patients: a systematic review
10.1007/s00432-020-03197-8 · 2020
Updated prognostic factors in localized NSCLC
10.3390/cancers14061400 · 2022
Updated prognostic factors in localized NSCLC
10.3390/cancers14061400 · doi-reference
Gender-specific differences in care-seeking behaviour among lung cancer patients: a systematic review
10.1007/s00432-020-03197-8 · doi-reference
Estrogens, cancer and immunity
10.3390/cancers14092265 · doi-reference
Sex differences in the response to lung cancer and its relation to programmed cell death protein-1/programmed death-ligand-1 checkpoint therapies
10.3390/cancers17243953 · doi-reference
Tumor-intrinsic determinants of immunogenic cell death modalities
10.1080/2162402x.2021.1893466 · doi-reference
Radiotherapy induced immunogenic cell death by remodeling tumor immune microenvironment
10.3389/fimmu.2022.1074477 · doi-reference
Sex-based dimorphism of anticancer immune response and molecular mechanisms of immune evasion
10.1158/1078-0432.ccr-21-0136 · doi-reference
Gender difference in treatment outcomes in patients with stage III non-small cell lung cancer receiving concurrent chemoradiotherapy
10.1093/jjco/hyp095 · doi-reference
Is sex associated with the outcome of patients treated with radiation for nonsmall cell lung cancer
10.1002/cncr.24361 · doi-reference
Trends and variations in treatment of stage I-III non-small cell lung cancer from 2008 to 2018: a nationwide population-based study from the Netherlands
10.1016/j.lungcan.2021.03.013 · doi-reference
Lung cancer, version 4.2024, NCCN clinical practice guidelines in oncology
10.6004/jnccn.2204.0023 · doi-reference
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up
10.1093/annonc/mdx222 · doi-reference
Insights into sex differences in perioperative outcomes of non-small cell lung cancer patients
10.21037/tlcr-24-336 · doi-reference
Sex and survival after surgery for lung cancer: a Swedish nationwide cohort
10.1016/j.chest.2020.11.010 · doi-reference
Evaluating prognostic factors for sex differences in lung cancer survival: findings from a large Australian cohort
10.1016/j.jtho.2022.01.016 · doi-reference
Survival differences by gender for resected non-small cell lung cancer: a retrospective analysis of 12,509 cases in a Japanese lung cancer registry study
10.1097/jto.0b013e3181f1923b · doi-reference
Sex differences in lung cancer treatment and outcomes at a large hybrid academic-community practice
10.1016/j.jtocrr.2022.100307 · doi-reference
Sex disparities in advanced non-small cell lung cancer survival: a Danish nationwide study
10.1016/j.lungcan.2025.108485 · doi-reference